Neurology News

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, presented new data on social anxiety disorder (SAD) at the 2025 Anxiety and Depression Association of America (ADAA) Conference in Las Vegas, Nevada. The Company’s poster presentations examined the age of onset of SAD in participants in...

NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--LinusBio, a leader in precision exposome medicine, and Autism Speaks, the leading research and advocacy organization dedicated to supporting the autism community, today announced a partnership to advance early autism diagnosis and intervention. As part of the collaboration, Autism Speaks will provide educational materials and resources to families concerned about autism, helping them better understand the potential of biomarker testing for earlier detecti...

TAMPA, Fla.--(BUSINESS WIRE)--Sila Realty Trust Completes $23.5 Million Acquisition of Dover Inpatient Rehabilitation Facility...

PARIS--(BUSINESS WIRE)--Artedrone, Truffle Capital’s medtech portfolio company developing an autonomous microrobotic solution for mechanical thrombectomy (MT) procedures to treat patients suffering from a stroke, announced the successful completion of a set of various in vitro and animal studies demonstrating the ability of the company’s SASHA microrobotic solution to autonomously perform mechanical thrombectomy. Results from the study are being submitted for publication in to a research journa...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases today announced the publication of a real-world clinical utility study in Multiple Sclerosis Journal – Experimental, Translational and Clinical entitled “Real-world clinical utility of a multi-protein, blood-based biomarker assay for disease activity assessments in multiple sclerosis.” The study eval...

ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--Abu Dhabi Launches Life Sciences Cluster to Advance Healthcare Innovation Worldwide, tapping a $25.3 trillion market...

MANHASSET, N.Y.--(BUSINESS WIRE)--Vulnerable populations, particularly those with Alzheimer’s disease and related dementias (ADRD), may experience greater health disparities due to the combined impact of socioeconomic stressors and their pre-existing cognitive impairments. These individuals are also known to be at even greater risk due to rising temperatures. To better investigate the impact of heat on stroke outcomes, particularly in this high-risk group, researchers at Northwell Health’s The...

BOSTON--(BUSINESS WIRE)--EveryONE Medicines, a company pioneering a scalable, global framework to design, develop, and manufacture individualized medicines for children with life-threatening neurodegenerative diseases, announced today the appointment of Michelle L. Mellion, MD, as Chief Medical Officer. In this role, Dr. Mellion will lead the development and execution of the Company’s clinical trials, the first of which is expected to be initiated in the United Kingdom (UK) later this year and...

BARCELONA, Spain & MARIN, Calif.--(BUSINESS WIRE)--Anaconda Biomed, S.L. has announced that results of the ANAIS Study, which evaluated the safety and performance of its ANA funnel catheter in the endovascular treatment of large vessel occlusion acute ischemic stroke, have been published in the American Journal of Neuroradiology. The data demonstrated high rates of reperfusion and first-pass success with a strong safety profile, supporting the ANA device as an adjunct to stent retriever thrombe...

CAMBRIDGE, Mass. & TÜBINGEN, Germany--(BUSINESS WIRE)--AIRNA today announced the appointment of Jacob Elkins, M.D., as Chief Medical Officer....